OverviewSuggest Edit

Organigram is a producer of medical cannabis and cannabis-derived products. The company offers indoor-grown cannabis for patients and adult recreational consumers. Its portfolio of legal adult use recreational cannabis brands includes Edison Cannabis, ANKR Organics, and Trailblazer.

TypePublic
Founded2013
HQMoncton, CA
Websiteorganigram.ca
Employee Ratings3

Latest Updates

Employees (est.) (Aug 2019)770(+117%)
Revenue (FY, 2019)C$80.4 M(+547%)
Share Price (Nov 2021)C$2.8(-3%)
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Organigram

Gregory Engel

Gregory Engel

Chief Executive Officer, Director
Amy Schwalm

Amy Schwalm

Vice President, Investor Relations
Paolo de Luca

Paolo de Luca

Chief Strategy Officer
Tim Emberg

Tim Emberg

Senior Vice President, Sales and Commercial Operations
Helen Martin

Helen Martin

Senior Vice President, Strategic and Legal Affairs
Derrick West

Derrick West

Chief Financial Officer
Show more

Organigram Office Locations

Organigram has offices in Moncton and Toronto
Moncton, CA (HQ)
35 English Dr
Toronto, CA
Bay Adelaide Centre, 333 Bay St #1250
Show all (2)

Organigram Financials and Metrics

Organigram Revenue

Embed Graph
View revenue for all periods
Organigram's revenue was reported to be C$80.41 m in FY, 2019 which is a 547% increase from the previous period.
CAD

Revenue (Q1, 2020)

25.2m

Gross profit (Q1, 2020)

11.2m

Gross profit margin (Q1, 2020), %

44.5%

Net income (Q1, 2020)

(863.0k)

EBIT (Q1, 2020)

154.0k

Market capitalization (10-Nov-2021)

835.1m

Closing stock price (10-Nov-2021)

2.8

Cash (30-Nov-2019)

34.0m

EV

885.6m
Organigram's current market capitalization is C$835.1 m.
Annual
CADFY, 2017FY, 2018FY, 2019

Revenue

5.4m12.4m80.4m

Revenue growth, %

131%547%

Cost of goods sold

8.7m4.7m31.9m

Gross profit

(3.3m)7.8m48.5m
Quarterly
CADQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Revenue

2.2m(581.2k)1.9m2.7m3.7m3.7m12.4m26.9m24.8m25.2m

Cost of goods sold

1.5m3.4m2.7m1.1m1.4m1.3m2.9m19.0m24.9m14.0m

Gross profit

762.9k(4.0m)(757.4k)1.6m2.3m2.4m9.5m8.0m(179.0k)11.2m

Gross profit Margin, %

34%684%(40%)60%63%65%77%30%(1%)45%
Annual
CADFY, 2017FY, 2018FY, 2019

Cash

55.1m55.1m47.6m

Accounts Receivable

793.0k793.0k11.9m

Prepaid Expenses

3.4m3.4m17.1m

Inventories

45.0m45.0m93.1m
Quarterly
CADQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Cash

7.6m1.3m2.7m7.6m53.7m31.6m30.2m12.5m47.2m34.0m

Accounts Receivable

514.0k1.1m541.6k514.0k995.0k795.0k11.2m21.7m14.6m13.5m

Prepaid Expenses

1.8m473.6k847.3k1.8m1.7m1.3m1.0m1.4m11.9m11.6m

Inventories

4.2m2.7m2.0m4.2m8.7m17.6m91.4m95.1m94.2m101.9m
Annual
CADFY, 2017FY, 2018FY, 2019

Net Income

(10.8m)22.1m(9.5m)

Depreciation and Amortization

1.6m3.5m8.9m

Inventories

1.3m(42.3m)(47.2m)

Accounts Payable

671.0k4.0m10.6m
Quarterly
CADQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Net Income

(1.4m)(6.5m)(8.9m)(1.4m)(324.1k)2.5m29.5m23.1m13.0m(863.0k)

Depreciation and Amortization

480.1k665.8k1.0m480.1k1.1m2.0m1.7m3.5m5.7m3.4m

Inventories

(1.6m)1.3m1.9m(1.6m)(6.1m)(14.9m)(46.5m)(50.2m)(49.2m)(8.8m)

Accounts Payable

513.5k2.7m1.5m513.5k5.5m2.4m(2.9m)(5.2m)3.2m(10.9m)
CADQ1, 2017

Financial Leverage

1.1 x
Show all financial metrics

Organigram Operating Metrics

Organigram's Patients was reported to be 18.1 k in Q1, 2020.
Q1, 2017Q2, 2017Q3, 2017Q4, 2017Q1, 2018Q2, 2018Q3, 2018Q4, 2018Q1, 2019Q2, 2019Q3, 2019Q4, 2019Q1, 2020

Brands

555443

Cannabis Harvested, kilograms

8.32 k6.05 k7.43 k12.76 k

Cannabis Sold, kilogram and kilogram equivalents

4.99 k4.62 k2.9 k5.5 k

Patients

4 k4.04 k5.51 k7.4 k10.73 k12.96 k15.32 k15.73 k13.51 k14.88 k17 k17.2 k18.13 k
Show all operating metrics

Organigram Acquisitions / Subsidiaries

Company NameDateDeal Size
Organigram Inc.

Organigram Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

30-39

out of 100

CSRHub logo

Organigram Online and Social Media Presence

Embed Graph

Organigram News and Updates

Canadian cannabis company Organigram buys Laurentian Organic

Organigram Holdings Inc. said Tuesday it acquired all of the issued and outstanding shares of Laurentian Organic Inc. for about $28 million plus additional earnout considerations based on 2022 and 2023 Ebitda benchmarks. The Laurentian acquisition will allow Organigram to reach into premium produc…

Organigram launches new 'SHRED'ems' lineup of cannabis-infused gummies

Organigram Holdings Inc. announced Wednesday the launch of its "SHRED'ems" lineup of "high-quality and bold" cannabis-infused gummies. The parent of Canada-based cannabis producer Organigram Inc., said "SHRED'ems" adds to its value-priced "SHRED" portfolio. The company said the vegan-friendly "SHRE…

Organigram tops revenue estimates in fiscal Q3 as loss narrows

Canadian cannabis company Organigram Holdings Inc. posted a narrower loss for its fiscal third quarter than in the same period a year ago as revenue topped estimates. The company posted a loss of C$4 million ($3.20 million) for the quarter to May 31, after a loss of C$89.9 million in the same perio…

Canadian cannabis company Organigram says CEO Greg Engel is stepping down with immediate effect

Organigram Holdings Inc. said Monday that Chief Executive Greg Engel is stepping down from his role effective today and will act as special adviser to the board through a transition period. The Moncton, New Brunswick-based cannabis company said Peter Amirault, currently chairman of the board, will …

UPDATE: OrganiGram stock slide 10% premarket as loss widens, revenue falls short of estimates as COVID weighs

OrganiGram Holdings Inc. said Tuesday it had a net loss of C$66.4 million ($52.8 million) in its fiscal second quarter to Feb. 28, wider than the loss of C$6.8 million posted in the year-earlier quarter. The Canadian cannabis company did not provide a per-share figure. Revenue fell to C$14.6 millio…

OrganiGram loss widens and revenue falls short of estimates in Q2 as COVID impacts staffing

OrganiGram Holdings Inc. said Tuesday it had a net loss of C$66.4 million ($52.8 million) in its fiscal second quarter to Feb. 28, wider than the loss of C$6.8 million posted in the year-earlier quarter. The Canadian cannabis company did not provide a per-share figure. Revenue fell to C$14.6 millio…
Show more

Organigram Frequently Asked Questions

  • When was Organigram founded?

    Organigram was founded in 2013.

  • Who are Organigram key executives?

    Organigram's key executives are Gregory Engel, Amy Schwalm and Paolo de Luca.

  • How many employees does Organigram have?

    Organigram has 770 employees.

  • What is Organigram revenue?

    Latest Organigram annual revenue is C$80.4 m.

  • What is Organigram revenue per employee?

    Latest Organigram revenue per employee is C$104.4 k.

  • Who are Organigram competitors?

    Competitors of Organigram include Aphria, Cronos Group and Trulieve.

  • Where is Organigram headquarters?

    Organigram headquarters is located at 35 English Dr, Moncton.

  • Where are Organigram offices?

    Organigram has offices in Moncton and Toronto.

  • How many offices does Organigram have?

    Organigram has 2 offices.